TELOMERE BIOLOGY DISORDERS
Clinical trials for TELOMERE BIOLOGY DISORDERS explained in plain language.
Never miss a new study
Get alerted when new TELOMERE BIOLOGY DISORDERS trials appear
Sign up with your email to follow new studies for TELOMERE BIOLOGY DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough transplant aims to cut immune drugs and infections in bone marrow failure patients
Disease control Recruiting nowThis study tests a special stem cell transplant that removes certain immune cells to lower the need for strong anti-rejection drugs. It is for people with inherited bone marrow failure disorders like Fanconi anemia. The goal is to help the immune system recover faster and reduce …
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New pill combo aims to help rare aging-like diseases
Disease control Recruiting nowThis early-stage study tests whether a combination of two natural substances (deoxycytidine and deoxythymidine) is safe for people with telomere biology disorders, which cause premature aging, bone marrow failure, and lung disease. About 36 participants will take the drug by mout…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Phase: PHASE1 • Sponsor: Suneet Agarwal • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
20-Year study aims to unlock secrets of rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows 1,000 people with bone marrow failure diseases for up to 20 years to learn how the diseases and treatments affect the body over time. Participants aged 2 and older, including family members, will have regular check-ups, blood tests, and other exams. The goal is…
Matched conditions: TELOMERE BIOLOGY DISORDERS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 12:02 UTC